Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2021

View Archived Issues

Osmol initiates IND-enabling studies of OSM-0205 for prevention of CIPN

Regeneron's REGN-7483F Mini-VEGF-Trap could be a next-generation VEGF inhibitor

Phase II/III XIRIUS study of cotoretigene toliparvovec in XLPR does not meet primary endpoint

SK Biopharmaceuticals divulges PRMT5 inhibitors

Gilead Sciences patents GLP-1R agonists

Kinnate Biopharma synthesizes new Raf kinase C inhibitors

ARKUDA Therapeutics identifies PGRN modulators

Shire Human Genetic Therapies describes new AAV-based gene therapy for HAE

CureVac reports promising preclinical data for its second-generation COVID-19 vaccine candidate

Combined administration of BNT-152 and BNT-153 results in synergistic antitumor effects

FDA approves Empaveli for PNH

Clinical results of an individualized multimodal immunotherapy

Phase II data on Sanofi and GSK COVID-19 vaccine candidate show favorable immune responses

Memo's MTX-COVAB shows efficacy against original SARS-CoV-2 and U.K. variant

Phase I results presented for rAAV9.U7snRNA.ACCA in DMD

Seelos reports open-label data on SLS-002 for acute suicidal ideation and behavior in MDD

New murine model of myotonic dystrophy 1 developed

Rise Biopharmaceuticals initiates phase I study of RP-72 in pancreatic cancer

Australian researchers map out first genetic profile of skeletal master regulator cells

Galera begins dosing in phase IIb study of GC-4711 in pancreatic cancer

Phase III trials of ruxolitinib in vitiligo meet endpoints

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...